Back to News
Market Impact: 0.3
India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India
Source: reuters.com
Healthcare & BiotechProduct Launches
Dr. Reddy's Laboratories signed an agreement with Takeda Pharmaceutical to promote and distribute Qdenga, a dengue vaccine, in India. The partnership expands Dr. Reddy's presence in vaccines and gives Takeda access to Dr. Reddy's Indian commercial distribution network.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.42
Ticker Sentiment
RDY0.55
TAK0.45
More News
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- Wells Fargo raises Abbvie stock price target to $340 on pipeline
- Citizens reiterates Ondas Holdings stock rating on IonStrike updates
- Wells Fargo raises Regeneron stock price target to $925 on execution
- Apple’s new CEO Ternus to face first earnings test as memory costs surge
- Deutsche Bank downgrades Novartis stock rating to sell on valuation